Analyst Ratings for Teva Pharma (TEVA)
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $45.00 (Goldman Sachs)
- Lowest: $35.00 (JPMorgan)
- Average: $39.38
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$39.38 (+26.8%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$39.38 (+26.8%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays » Updated 1/30/2026 |
Glen Santangelo | New Coverage | Overweight (N/A) |
38.00 (35.00) |
28.46 (31.05) |
9.1% | Details |
| 12/5/2025 | Scotiabank » Updated 1/29/2026 |
Louise Chen | New Coverage | Sector Outperform (N/A) |
40.00 (35.00) |
27.83 (31.05) |
11.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
